DP
AFIB

DSAM Partners’s Acutus Medical Inc AFIB Stock Holding History

DSAM Partners’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-71,848
Closed -$1.22M – 48
2021
Q2 		$1.22M Hold
71,848
– – 0.2% 44
2021
Q1 		$961K Buy
71,848
+18,923
+36% +$426K 0.18% 46
2020
Q4 		$1.52M Buy
+52,925
New +$1.43M 0.18% 56

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $263M AUM 40.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

DSAM Partners's AFIB Position: Q3 2021 in Review

DSAM Partners sold out of Acutus Medical Inc (AFIB) in Q3 2021, closing a stake of 71,848 shares — an estimated $1.22M sold.

DSAM Partners first reported a position in AFIB in Q4 2020 and held it in 3 quarters. The position peaked at $1.52M in Q4 2020. 70 funds tracked by Wall St. Rank hold AFIB as of Q3 2021.

  • DSAM Partners reported no remaining Acutus Medical Inc position as of Q3 2021 after selling out during the quarter.
  • DSAM Partners sold 71,848 Acutus Medical Inc shares in Q3 2021, an estimated $1.22M.
  • DSAM Partners first reported a position in Acutus Medical Inc in Q4 2020 and held it in 3 quarters.
  • DSAM Partners's Acutus Medical Inc position peaked at $1.52M in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2021.

Based on DSAM Partners's 13F filing for Q3 2021, filed 15 Nov 2021.